My watch list
my.chemeurope.com  

my.chemeurope.com

With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.

  • My watch list
  • My saved searches
  • My saved topics
  • My newsletter
Register free of charge
Login  
eng  
DeutschEnglishFrançaisEspañol

Ipratropium/salbutamol



Ipratropium/salbutamol
Combination of
Ipratropium Muscarinic antagonist
Salbutamol Short-acting β2-adrenergic agonist
Identifiers
CAS number  ?
ATC code  ?
PubChem  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes Inhalation

The combination preparation ipratropium/salbutamol is a formulation containing ipratropium bromide and salbutamol sulfate (albuterol sulfate) used in the management of chronic obstructive pulmonary disease (COPD) and asthma. It is marketed by Boehringer Ingelheim as metered dose inhaler (MDI) and nebuliser preparations under the trade name Combivent.

v • d • e
Drugs for obstructive airway diseases: asthma/COPD (R03)
Adrenergics, inhalantsShort acting β2-agonists: Salbutamol/Levosalbutamol • Fenoterol • Terbutaline
Long acting β2-agonists (LABA): Bambuterol • Clenbuterol • Formoterol • Salmeterol
other: Epinephrine • Isoproterenol • Orciprenaline
GlucocorticoidsBeclometasone • Budesonide • Ciclesonide • Fluticasone • Mometasone
AnticholinergicsIpratropium • Tiotropium
Mast cell stabilizersCromoglicate • Nedocromil
XanthinesAminophylline • Theobromine • Theophylline
Leukotriene antagonistsMontelukast • Pranlukast • Zafirlukast
Combination productsBudesonide/formoterol • Fluticasone/salmeterol • Ipratropium/salbutamol
 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Ipratropium/salbutamol". A list of authors is available in Wikipedia.
Last viewed
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE